Truist Financial Corp Grifols Sa Transaction History

Truist Financial Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$16.28 - $25.63 $535,888 - $843,662	-32,917 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$19.57 - $23.52 $45,050 - $54,143	-2,302 Reduced 6.54%	32,917 $766,000
Q3 2019 Oct 31, 2019	BUY	$19.85 - $22.76 $17,011 - $19,505	857 Added 2.49%	35,219 $706,000
Q2 2019 Jul 24, 2019	SELL	$17.59 - $21.1 $3,166 - $3,798	-180 Reduced 0.52%	34,362 $725,000
Q1 2019 Apr 23, 2019	SELL	$18.01 - $20.11 $16,227 - $18,119	-901 Reduced 2.54%	34,542 $695,000
Q4 2018 Jan 22, 2019	BUY	$17.44 - $21.53 $6,034 - $7,449	346 Added 0.99%	35,443 $651,000
Q3 2018 Oct 17, 2018	SELL	$19.97 - $21.96 $24,103 - $26,505	-1,207 Reduced 3.32%	35,097 $750,000
Q2 2018 Jul 26, 2018	SELL	$20.16 - $24.68 $32,901 - $40,277	-1,632 Reduced 4.3%	36,304 $781,000
Q1 2018 Apr 20, 2018	SELL	$20.31 - $24.95 $32,008 - $39,321	-1,576 Reduced 3.99%	37,936 $804,000
Q4 2017 Jan 29, 2018	SELL	$20.99 - $23.89 $7,556 - $8,600	-360 Reduced 0.9%	39,512 $905,000
Q3 2017 Oct 23, 2017	BUY	$20.07 - $21.89 $800,231 - $872,798	39,872	39,872 $873,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Truist Financial Corp with notifications on news.